Vrijens Bernard, Antoniou Sotiris, Burnier Michel, de la Sierra Alejandro, Volpe Massimo
WestRock HealthcareVisé, Belgium; Department of Public Health, University of LiègeLiège, Belgium.
Barts Health NHS Trust London, UK.
Front Pharmacol. 2017 Mar 1;8:100. doi: 10.3389/fphar.2017.00100. eCollection 2017.
Despite increased awareness, poor adherence to treatments for chronic diseases remains a global problem. Adherence issues are common in patients taking antihypertensive therapy and associated with increased risks of coronary and cerebrovascular events. Whilst there has been a gradual trend toward improved control of hypertension, the number of patients with blood pressure values above goal has remained constant. This has both personal and economic consequences. Medication adherence is a multifaceted issue and consists of three components: initiation, implementation, and persistence. A combination of methods is recommended to measure adherence, with electronic monitoring and drug measurement being the most accurate. Pill burden, resulting from free combinations of blood pressure lowering treatments, makes the daily routine of medication taking complex, which can be a barrier to optimal adherence. Single-pill fixed-dose combinations simplify the habit of medication taking and improve medication adherence. Re-packing of medication is also being utilized as a method of improving adherence. This paper presents the outcomes of discussions by a European group of experts on the current situation of medication adherence in hypertension.
尽管人们的认识有所提高,但慢性病治疗的依从性差仍然是一个全球性问题。依从性问题在接受抗高血压治疗的患者中很常见,并与冠状动脉和脑血管事件风险增加相关。虽然高血压控制有逐渐改善的趋势,但血压值高于目标值的患者数量一直保持不变。这会产生个人和经济后果。药物依从性是一个多方面的问题,包括三个组成部分:起始、实施和持续。建议采用多种方法来衡量依从性,其中电子监测和药物测量最为准确。降压治疗自由组合导致的药片负担,使日常服药变得复杂,这可能成为最佳依从性的障碍。单片固定剂量组合简化了服药习惯,提高了药物依从性。重新包装药物也被用作提高依从性的一种方法。本文介绍了一组欧洲专家关于高血压药物依从性现状讨论的结果。